Viewing Study NCT04913220


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2025-12-26 @ 3:13 AM
Study NCT ID: NCT04913220
Status: TERMINATED
Last Update Posted: 2025-03-05
First Post: 2021-05-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module